Sharon Surrey Barbari is a director of VYNE Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
AGILE THERAPEUTICS INC
26 Aug 24
4
VYNE Therapeutics Inc.
3 Jan 24
4
VYNE Therapeutics Inc.
15 Dec 23
4
AGILE THERAPEUTICS INC
9 Jun 23
4
VYNE Therapeutics Inc.
12 Aug 22
4
AGILE THERAPEUTICS INC
10 Jun 22
4
VYNE Therapeutics Inc.
20 Jul 21
4
AGILE THERAPEUTICS INC
10 Jun 21
4
Menlo Therapeutics Inc.
21 Aug 20
4
Menlo Therapeutics Inc.
5 Aug 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Aug 24 | AGXRW Agile Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 1.52 | 973 | 1.48 k | 0 |
1 Jan 24 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.33 | 20,000 | 46.60 k | 20,000 |
13 Dec 23 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.7 | 20,000 | 54.00 k | 20,000 |
8 Jun 23 | AGXRW Agile Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 935 | 0.00 | 974 |
8 Jun 23 | AGXRW Agile Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 3.58 | 1,065 | 3.81 k | 1,065 |